Perk Labs Inc.
PKLBF · OTC
8/31/2023 | 5/31/2023 | 2/28/2023 | 11/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -74.7% | 1,352.5% | -75.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 9.5% | 0.1% | 44.6% | 20.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5,943.1% | -1,670.1% | -4,652.7% | -4,252.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5,954.9% | -1,757% | -5,627.7% | -5,010.5% |
| EPS Diluted | -0.001 | -0.002 | -0.001 | -0.003 |
| % Growth | 23.5% | -142.9% | 75% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |